Phosphono analogues of 2-oxoglutarate protect cerebellar granule neurons upon glutamate excitotoxicity.
Glutamate excitotoxicity is an important contributor to neuronal loss. Glutamate-induced Ca(2+) deregulation and accompanying mitochondrial depolarization are closely associated with the onset of apoptotic and necrotic neuronal death. We investigated the role in these phenomena of 2-oxoglutarate dehydrogenase (OGDH), the enzyme participating in mitochondrial degradation of glutamate. To achieve this goal, we used specific effectors of cellular OGDH, succinyl phosphonate and its phosphonoethyl ether. Preincubation of cerebellar granule neurons with these phosphono analogues of 2-oxoglutarate was shown to protect the cells from glutamate-induced Ca(2+) deregulation and irreversible mitochondrial depolarization, followed simultaneously by fluorescence of fura-2FF and rhodamine 123, respectively. The protection was characterized by delay in onset and decreased propagation of Ca(2+) deregulation and by reversibility of the associated mitochondrial depolarization. Compared to its phosphonoethyl ether, succinyl phosphonate exhibited both higher affinity to OGDH in vitro and better protection from Ca(2+) deregulation in situ, supporting the assumption that neuroprotection by phosphonates involves their interaction with cellular OGDH. Preincubation of cerebellar granule neurons with succinyl phosphonate decreased neuronal death after excitotoxic action of glutamate. Thus, specific inhibitors of OGDH alleviate glutamate-induced calcium deregulation, mitochondrial depolarization, and neuronal death.
Bunik
Victoria I
VI
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia. bunik@belozersky.msu.ru
Kabysheva
Maria S
MS
Klimuk
Eugeny I
EI
Storozhevykh
Tatiana P
TP
Pinelis
Vsevolod G
VG
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000473:pathology; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005971:Glutamates / Q000633:toxicity*; D007655:Ketoglutarate Dehydrogenase Complex / Q000037:antagonists & inhibitors / Q000378:metabolism; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D063065:Organophosphonates / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013386:Succinates / Q000737:chemistry / Q000494:pharmacology*
D005971:Glutamates; D063065:Organophosphonates; D013386:Succinates; C099145:succinyl phosphonate; D007655:Ketoglutarate Dehydrogenase Complex; D002118:Calcium